Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving leading biopharmaceutical companies globally:
Generated: April 20, 2018
DrugPatentWatch Database Preview
Vidara Therapeutics Research Ltd Company Profile
Summary for Applicant: Vidara Therapeutics Research Ltd
| Patents: | 35 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| BLAs: | 1 |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Inventors | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vidara Therapeutics Research Ltd | ACTIMMUNE | interferon gamma-1b | VIAL; SINGLE-USE | 103836 | 001 | 1999-02-25 | 6,347,633 | First Circle Medical, Inc. (Minneapolis, MN) | Groth; Karl Emil (St. Paul, MN), Kelly; Theodore Charles (Minnetonka, MN), Westerbeck; Todd L. (Burnsville, MN), Blick; Gary (Stamford, CT) | ➤ Sign Up | RX | search | |
| Vidara Therapeutics Research Ltd | ACTIMMUNE | interferon gamma-1b | VIAL; SINGLE-USE | 103836 | 001 | 1999-02-25 | 6,415,797 | First Circle Medical, Inc. (Minneapolis, MN) | Groth; Karl Emil (St. Paul, MN), Kelly; Theodore Charles (Minnetonka, MN), Westerbeck; Todd L. (St. Paul, MN), Blick; Gary (Stamford, CT) | ➤ Sign Up | RX | search | |
| Vidara Therapeutics Research Ltd | ACTIMMUNE | interferon gamma-1b | VIAL; SINGLE-USE | 103836 | 001 | 1999-02-25 | 6,642,274 | Neal; Gary W. (Knoxville, TN) | ➤ Sign Up | RX | search | ||
| Vidara Therapeutics Research Ltd | ACTIMMUNE | interferon gamma-1b | VIAL; SINGLE-USE | 103836 | 001 | 1999-02-25 | 6,644,320 | First Circle Medical, Inc. (Minneapolis, MN) | Groth; Karl Emil (St. Paul, MN), Kelly; Theodore Charles (Minnetonka, MN), Westerbeck; Todd L. (Burnsville, MN), Blick; Gary (Stamford, CT) | ➤ Sign Up | RX | search | |
| This preview shows a limited number of results Subscribe for full access, or try a Trial | |||||||||||||
Export unavailable in trial.
Subscribe for complete access.
For more information try a trial or see the plans and pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Get our Free Drug Patent Bulletin
Join the 23,402 others who get our Drug Patent Expiration Alerts:
- Articles on vital topics
- Fresh industry trends
- Expiring drug patents
- More …
